Dyadic International (DYAI US)

Analysis

Health Care • United States

Dyadic International, Inc. is a global biotechnology company. The Company focuses on improving and applying the proprietary C1 expression system to help drug developers and manufacturers bring biologic drugs to market. Dyadic International focuses on drugs that will improve access and cost to patients as well as save lives.

Refresh

Company Event • 13 Aug 2026 05:00 • Upcoming

Add To Calendar

Q2 2026

Company Event • 28 May 2026 22:30 • Latest

Lytham Partners Spring 2026 Investor Conference

Company Event • 20 May 2026 22:00

Sidoti Micro-Cap Virtual Conference

Company Event • 19 May 2026 19:00 • Upcoming

Add To Calendar

Investor presentation

Company Event • 14 May 2026 05:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Q2 2026

Lytham Partners Spring 2026 Investor Conference

Sidoti Micro-Cap Virtual Conference

Investor presentation

Q1 2026